Citrate capped superparamagnetic iron oxide nanoparticles used for hyperthermia therapy

Abstract

Superparamagnetic magnetite nanoparticles (MNP) of about 10 nm were designed with proper physico-chemical characteristics by an economic, biocompatible chemical coprecipitation of Fe2+ and Fe3+ in an ammonia solution, for hyperthermia applications. Synthetic methodology has been developed to get a well dispersed and homogeneous aqueous suspension of MNPs. Citric acid was used to stabilize the magnetite particle suspension, it was anchored on the surface of freshly prepared MNPs by direct addition method. Carboxylic acid terminal group not only render the particles more water dispersible but also provides a site for further surface modification. The naked MNPs are often insufficient for their stability, hydrophilicity and further functionalization. To overcome these limitations, citric acid was conjugated on the surface of the MNPs. The microstructure and morphology of the nanoparticles were characterized by X-ray diffraction (XRD) and transmission electron microscopy (TEM), and the interaction between citric acid and MNPs were characterized by Fourier transform infrared spectroscopy (FTIR), whereas the magnetic properties were investigated by vibrating sample magnetometry (VSM). Magnetic measurement revealed that the saturation magnetization of the nanoparticles was 74 emu/g and the nanoparticles were superparamagnetic at room temperature. We also have analyzed the potential of these particles for hyperthermia by determination of the specific absorption rate, the temperature increase (ΔT) of the particles was 37oC. These ferrofluids with high self-heating capacity are a promising candidate for cancer hyperthermia treatment.

Share and Cite:

Cheraghipour, E. , Javadpour, S. and Mehdizadeh, A. (2012) Citrate capped superparamagnetic iron oxide nanoparticles used for hyperthermia therapy. Journal of Biomedical Science and Engineering, 5, 715-719. doi: 10.4236/jbise.2012.512089.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Dandamudi, S. and Robert B. C. (2007) The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials, 28, 4673-4683. doi:10.1016/j.biomaterials.2007.07.024
[2] Li, Z., Li, M., Kawashita, Araki, N., Mitsumori, M., Hiraoka, M. and Doi, M. (2010) Magnetite nanoparticles with high heating efficiencies for application in the hyperthermia of cancer. Materials Science and Engineering: C, 30, 990-996. doi:10.1016/j.msec.2010.04.016
[3] Wang, Y., Xu, F., Zhang, C., Lei, D., Tang, Y., Xu, H., Zhang, Z., Lu, H., Du, X. and Yang, G. (2011) MR high, sensitive fluorescent magnetite nanocluster for stem cell tracking in ischemic mouse brain. Nanomedicine: Nano-technology, Biology and Medicine, 6, 1009-1019. doi:10.1016/j.nano.2011.03.006
[4] Parveen, S., Misra, R. and Sahoo, S. K. (2011) A boon to drug delivery, therapeutics, diagnostics and imaging. Nano-medicine, Nanotechnology, Biology, and Medicine, 2, 147-166.
[5] Mahmoudi, M., Simchi, A. and Imani, M. (2010) Recent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applications. Journal of the Iranian Chemical Society, 7, 1-27.
[6] Mornet, S., Portier, J. and Duguet, E. (2005) A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran. Journal of Magnetism and Magnetic Materials, 293, 127-134. doi:10.1016/j.jmmm.2005.01.053
[7] Jain, T.K., Morales, M.A., Sahoo, S.K., Leslie-Pelecky, D.L. and Labhasetwar V. (2005) Iron oxide nanoparticles for sustained delivery of anticancer agents. Molecular Pharmaceutics, 2, 194-205. doi:10.1021/mp0500014
[8] Vayssieres, L., Chaneac, C., Troc, E. and Jolivet, J.P. (1998) Size tailoring of magnetite particles formed by aqueous precipitation: an example of thermodynamic stability of nanometric oxide particles. The Journal of Colloid and Interface Science, 205, 205-205. doi:10.1006/jcis.1998.5614
[9] Sahoo, Y., Goodarzi, A., Swihart, M.T., Ohulchanskyy, T.Y., Kaur, N., Furlani, E.P. and Prasad, P.N. (2005) Aqueous ferrofluid of magnetite nanoparticles: Fluorescence labeling and magnetophoretic control. Australian Journal of Chemistry B., 109, 3879-3885. doi:10.1021/jp045402y
[10] Liu, C. and Huang, P.M. (1999) Atomic force microscopy and surface characteristic of iron oxides formed in citrate solution. Soil Science Society of America Journal, 63, 65-72. doi:10.2136/sssaj1999.03615995006300010011x
[11] Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L. and Muller, R. (2008) Magnetic iron ox- ide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations and biological applications. Chemistry Reviews, 108, 2064-2110. doi:10.1021/cr068445e
[12] Bee, A., Massart, R. and Neveu, S. (1995) Synthesis of very fine maghemite particles. Journal of Magnetism and Magnetic Materials, 149, 6-9. doi:10.1016/0304-8853(95)00317-7
[13] Nielsen, O.S., Horsman, M. and Overgaard, J. (2001) A future for hyperthermia in cancer treatment. European Journal of Cancer, 37, 1587-1589. doi:10.1016/S0959-8049(01)00193-9
[14] Gazeau, F., Levy, M. and Wilhelm, C. (2008) Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine, 3, 831-844. doi:10.2217/17435889.3.6.831
[15] Levy, L., Sahoo, Y., Kim, K., Bergey, E.J. and Prasad, P.N. (2002) Nanochemistry: Synthesis and characterization of multifunctional nanoclinics for biological applications. Chemistry of Materials, 14, 3715-3720. doi:10.1021/cm0203013
[16] Sahoo, Y., Goodarzi, A., Swihart, M.T., Ohulchanskyy, T.Y., Kaur, N., Furlani, E.P. and Prasad, P.N. (2005) Aqueous ferrofluid of magnetite nanoparticles: Fluorescence labeling and magnetophoretic control. Australian Journal of Chemistry B., 109, 3879-3885. doi:10.1021/jp045402y
[17] Nigam, S., Barick, K.C. and Bahadur, D. (2011) Deve- lopment of citrate-stabilized Fe3O4 nanoparticles: Conjugation and release of doxorubicin for the rapeuticapplications. Journal of Magnetism and Magnetic Materials, 323, 237-243. doi:10.1016/j.jmmm.2010.09.009
[18] Racuciu, M., Creanga, D.E. and Airinei, A. (2006) Citric-acid-coated magnetite nanoparticles for biological applications. European Physical Journal E (EPJE), 21, 117-121. doi:10.1140/epje/i2006-10051-y
[19] Levy, L., Sahoo, Y., Kim, K., Bergey, E.J. and Prasad, P.N. (2002) Nanochemistry: Synthesis and characterization of multifunctional nanoclinics for biological applications. Chemistry of Materials, 14, 3715-3720. doi:10.1021/cm0203013
[20] Giri, J., Pradhan, P., Sriharsha, T. and Bahadur, D. (2005) Preparation and investigation of potentiality of different soft ferrites for hyperthermia applications. Journal of Applied Physics, 97, 910-916. doi:10.1063/1.1855131

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.